Related Experiment Video
Updated: Jul 14, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
[Steroids in the critical care children with septic shock and other conditions]
1Département d'anesthésie et de réanimation pédiatrique, CHU Timone-Enfants et université de la Méditerranée, faculté de médecine, Marseille cedex 05, France.
Insights
Steroids in pediatric intensive care have varied uses, but evidence for their benefit in pediatric septic shock is lacking. However, steroids can improve outcomes in neonates after cardiac surgery and in treating croup and bacterial meningitis.
Area of Science:
- Pediatric Intensive Care Medicine
- Pediatric Pharmacology
- Pediatric Critical Care
Context:
- Steroids are used in pediatric intensive care for anti-inflammatory and substitutive purposes.
- Adrenal insufficiency (AI) incidence in pediatric septic shock ranges from 18-52%.
- Unlike adults, pediatric septic shock lacks sufficient evidence for steroid benefits on outcomes.
Purpose:
- To review the current evidence and indications for steroid use in pediatric intensive care.
- To evaluate the efficacy and safety of steroids in various pediatric critical conditions.
- To provide guidance on appropriate steroid dosing and application in neonates and children.
Summary:
- In neonates, steroids improve hemodynamics post-cardiac surgery (30-100 mg/m²/d hydrocortisone).
- Dexamethasone reduces stridor and reintubation in neonates and infants, and improves croup symptoms.
- Steroids are indicated for severe asthma and bacterial meningitis, improving neurological outcomes and reducing mortality.
Impact:
- Steroid use in pediatric septic shock requires further investigation due to lack of demonstrated outcome benefits.
- Steroids are beneficial in specific neonatal and pediatric conditions like post-cardiac surgery, croup, and meningitis.
- Potential central nervous system side effects limit steroid use in bronchopulmonary dysplasia.
Abstract:
Steroids are indicated in paediatric intensive care as anti-inflammatory drugs or for substitutive treatment. During septic shock, the incidence of adrenal insufficiency (AI) varies between 18 à 52%, depending on the relative or absolute nature of the AI. Contrary to adults, for whom long courses of low doses of corticosteroids were shown to reduce mortality and increased shock reversibility, particularly in those with a negative synacthene test, no study provided sufficient evidence to show a benefit of steroids in terms of outcome in children with septic shock. In neonates, AI occurs frequently after cardiac surgery and the administration of steroids can improve haemodynamic condition. The recommended dose of hydrocortisone during septic shock or after cardiac surgery is 30 to 100 mg/m(2)/d. Dexamethasone is efficient to reduce postextubation stridor in children and neonate and the rate of reintubations in neonate. During croup, oral or parenteral steroids reduce clinical symptoms. Dexamethasone also reduces the incidence of severe chronic lung disease and the duration of tracheal intubation in premature infants. However the high incidence of side effects, particularly on the central nervous system, makes steroids currently not recommended for bronchopulmonary dysplasia. At last, steroids are indicated for severe asthma and for bacterial meningitis. In this latter indication, dexamethasone was shown to improve neurological outcome, indeed mortality in Haemophilus influenzae and Streptococcus pneumoniae meningitis.
More Related Videos
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Pharmacokinetics in Pediatric Patients: Drug Metabolism
